Mod GRF, Ipamorelin, GHRP-2 (Blend)
$95.00
PRODUCT SHORT DESCRIPTION
The Mod GRF, Ipamorelin & GHRP-2 research blend integrates three distinct growth hormone secretagogues to model multi-receptor regulation within the somatotropic axis. This formulation provides a comprehensive biochemical tool for investigating maximum growth hormone pulsatility and receptor signaling crosstalk.
The Mod GRF, Ipamorelin & GHRP-2 Blend is a sophisticated, multi-component research peptide formulation integrating three distinct growth hormone secretagogues into a single, uniform lyophilized matrix. Supplied at ≥98% purity, this triple-pathway blend is available exclusively at The Peptide Store as a precision biochemical tool for advanced endocrinological and somatotropic axis research. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
The Mod GRF, Ipamorelin & GHRP-2 Blend is engineered to provide research laboratories with a comprehensive, synergistic platform for investigating multi-receptor growth hormone regulation. By combining a Growth Hormone-Releasing Hormone (GHRH) analog with two structurally distinct Growth Hormone Secretagogue Receptor (GHSR) agonists, this formulation enables simultaneous modeling of triple-pathway receptor signaling crosstalk within the somatotropic axis. This integrated presentation eliminates compounding weighing variables and streamlines experimental workflows in high-resolution endocrinology studies.
Peptide Structure & Amino Acid Sequence
This blend incorporates three well-characterized peptide compounds, each with a defined primary sequence and receptor target profile:
- Mod GRF (1-29) — A truncated, stabilized analog of endogenous GHRH. Its 29-amino acid sequence is modified at key positions to resist enzymatic degradation while preserving full GHRH receptor (GHRHR) agonist activity, enabling sustained stimulation of pituitary somatotrophs.
- Ipamorelin — A selective pentapeptide GHSR agonist (His-Aib-Trp-D-Phe-Lys-NH₂) notable for its high receptor selectivity and minimal off-target secretagogue activity, making it a valuable research comparator compound.
- GHRP-2 (Pralmorelin) — A synthetic hexapeptide GHSR agonist (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) recognized for potent, dose-dependent GH pulse amplification and established use in neuroendocrine signaling studies.
The co-formulation of these three agents in a single lyophilized matrix allows researchers to investigate synchronized receptor activation, competitive binding kinetics, and downstream signal transduction cascades simultaneously.
Chemical & Physical Characteristics
- Formulation Type: Triple-component lyophilized peptide blend
- Physical State: White to off-white lyophilized cake or powder
- Solubility: Soluble in aqueous buffers; refer to laboratory-grade reconstitution protocols for research applications
- Stability: Stable under recommended storage conditions; lyophilized form maximizes long-term integrity
- Molecular Composition: Three distinct peptide sequences co-lyophilized into a single uniform matrix
Purity & Analytical Verification (HPLC & MS)
Each production batch of the Mod GRF, Ipamorelin & GHRP-2 Blend undergoes rigorous analytical verification to confirm identity, purity, and compositional integrity. All three peptide components are independently validated at ≥98% purity prior to blending. Final batch release is contingent upon passing both High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis, ensuring accurate molecular weight confirmation and absence of significant impurities or degradation byproducts. Certificates of Analysis (CoA) reflecting these results are available for qualified research purchasers upon request.
Quality Control & Lyophilization Integrity
The lyophilization process employed for this blend is conducted under controlled pharmaceutical-grade conditions to preserve the structural integrity and bioactivity profile of all three peptide components. Lyophilization removes residual moisture to levels that minimize hydrolytic degradation during storage and transit. Each vial is sealed under inert conditions to prevent oxidative exposure. Batch-level quality control protocols encompass identity testing, purity profiling, and physical appearance inspection prior to release for distribution.
Safety, Handling & Laboratory Precautions
This product is intended solely for use by qualified research scientists in properly equipped laboratory settings. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and appropriate lab attire — should be worn when handling lyophilized peptide material. Researchers should consult applicable institutional biosafety guidelines and Material Safety Data Sheets (MSDS) before use. This blend is not approved for any in vivo, clinical, or consumptive application.
Reconstitution, Packaging & Storage
The Mod GRF, Ipamorelin & GHRP-2 Blend is supplied as a lyophilized solid in sealed research-grade vials. Reconstitution should be performed using sterile, laboratory-grade solvents appropriate to the specific in vitro research protocol being conducted. Upon reconstitution, solutions should be aliquoted promptly and stored according to established laboratory best practices. Lyophilized product should be stored at -20°C or below, protected from light and moisture, to maintain maximum stability. Avoid repeated freeze-thaw cycles of reconstituted solutions.
Intended Research Use & Market Positioning
The Mod GRF, Ipamorelin & GHRP-2 Blend is specifically positioned as a high-value research tool for endocrinology laboratories, academic institutions, and pharmaceutical research organizations investigating somatotropic axis regulation, GH pulsatility modeling, neuroendocrine feedback mechanisms, and multi-receptor secretagogue crosstalk. The pre-blended, single-vial format offers a distinct logistical advantage over sourcing and weighing individual components separately, reducing experimental variability and preparation time. This product is not intended, marketed, or sold for any therapeutic, clinical, or personal use purpose.
Ordering, Availability & Fulfillment
The Peptide Store offers the Mod GRF, Ipamorelin & GHRP-2 Blend for sale online with secure ordering, competitive best-price positioning, and reliable fulfillment for qualified research buyers. Order now through our streamlined eCommerce platform to take advantage of fast dispatch, discreet research-grade packaging, and dedicated customer support. Bulk research quantities and institutional procurement inquiries are welcomed — contact our team for volume pricing details.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Mod GRF, Ipamorelin & GHRP-2 Blend is sold exclusively as a laboratory research reagent. It has not been evaluated by any regulatory authority for safety or efficacy in humans or animals. The Peptide Store makes no therapeutic claims regarding this product. All purchasers are solely responsible for ensuring compliance with applicable local, national, and international laws and regulations governing the purchase, possession, and use of research peptides. This product must not be used in any manner inconsistent with its research-only designation.
Related products
Fragment, Modified GRF, Ipamorelin 12mg (Blend)
PRODUCT SHORT DESCRIPTION
The Fragment, Modified GRF, and Ipamorelin formulation delivers an advanced, triple-action 12mg (12000mcg) research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility, and parallel lipid metabolism pathways.
GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-2 (5mg x 5) and CJC-1295 no DAC (5mg x 5)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing five 5mg vials of GHRP-2 alongside five 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
GHRP-6 (5mg x 5) and CJC-1295 No DAC (5mg x 5)
GHRP-6 (5mg x 5) and CJC-1295 No DAC (5mg x 5) from The Peptide Store is a dual-mechanism secretagogue research kit supplied at ≥98% purity, offering five 5mg vials of each peptide for standardized somatotropic axis research. This multi-vial configuration is engineered for investigating dual-receptor GH pulsatility, neuroendocrine coordination, and downstream endocrine signaling kinetics in preclinical model systems. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
GHRP-6 10mg
PRODUCT SHORT DESCRIPTION
GHRP-6 10mg is a premium, high-purity synthetic hexapeptide engineered for advanced somatotropic and metabolic axis evaluation. This 10mg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, intracellular signaling mechanisms, and pulsatile growth hormone (GH) transcription.
Hexarelin (2mg x 10), CJC-1295 No DAC (2mg x 10)
The Hexarelin (2mg x 10) and CJC-1295 No DAC (2mg x 10) research kit from The Peptide Store delivers a high-resolution, dual-secretagogue platform comprising ten 2mg vials of each peptide at ≥98% purity, verified by HPLC and mass spectrometry. This standardized combination kit is engineered for investigating dual-receptor somatotroph coordination, GH pulsatility dynamics, and downstream endocrine signaling kinetics. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Hexarelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The Hexarelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of Hexarelin alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
Hexarelin 5mg
PRODUCT SHORT DESCRIPTION
Hexarelin 5mg is a premium, high-purity synthetic hexapeptide engineered for advanced endocrine and cardiovascular axis evaluation. This 5000mcg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, structural cardiac cell preservation, and maximum growth hormone (GH) pulsatility.

Reviews
There are no reviews yet.